FluMist Home is an influenza vaccine that’s administered via nasal spray, which means no needles and no waiting in line at ...

If you are in one of 34 states, you can now order AstraZeneca's FluMist Home vaccine online to be delivered to your home ...

The flu vaccine is crucial, especially for older adults, heart patients, and children, as the flu can lead to severe ...

Once eligibility requirements are met, the needle-free nasal spray can be self-administered by adults ages 18 to 49. Adults ...

AstraZeneca has launched FluMist Home, a nasal spray flu vaccine with at-home delivery service. For those who have a needle ...

FLUMIST, AstraZeneca’s FDA-approved flu nasal vaccine, can now be ordered and used at home with zero needles or clinic hassle ...

AstraZeneca has issued its flu vaccine nasal spray for at-home use. The nasal spray is authorized for use by adults ages 18-49 and for caregiver use with children ages 2-17, according to an Aug. 15 ...

The approval of the new nasal spray comes ahead of this year's influenza season in hopes to prevent the unusually high ...

Vaccination remains pivotal in mitigating influenza's impact, yet existing vaccines have limitations, including variable effectiveness. Prioritizing vaccination for high-risk groups is crucial.

Influenza vaccine uptake, hospitalizations, and microbiology testing records were collected from birth until age 7 years or December 31, 2013, whichever came first.

HHS reinstates vaccine safety task force apparently in response to looming lawsuit deadline by group Secretary Kennedy ...

Australian biotech giant CSL Ltd on Tuesday announced plans to demerge its influenza vaccine division, CSL Seqirus, and said it will lay off up to 15% of its workforce, after reporting a strong growth ...